| AUC | Area under the drug-time curve |
| BAEE | N-benzoyl-L-arginine ethyl ester hydrochloride |
| BBB | Blood–brain barrier |
| B/P | Blood-to-plasma |
| cAMP | Cyclic adenosine monophosphate |
| Cmax | Maximum plasma concentration |
| CNS | Central nervous system |
| COPD | Chronic obstructive pulmonary disease |
| DMSO | Dimethyl sulfoxide |
| ESI | Electrospray ionization |
| HQC | High-quality control |
| HSA | Human serum albumin |
| IS | Internal standard |
| ISR | Incurred sample reanalysis |
| LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| LLOQ | Lower limit of quantitation |
| LQC | Low-quality control |
| MQC | Medium-quality control |
| MRM | Multiple reaction monitoring |
| MRT | Mean residence time |
| NSB | Non-specific binding |
| PDE4 | Phosphodiesterase 4 |
| QC | Quality control |
| RE | Relative error |
| RSD | Relative standard deviation |
| SD | Standard deviation |
| S/N | Signal-to-noise ratio |
| SPF | Specific pathogen-free |
| t1/2 | Elimination half-life |
| ULOQ | Upper limit of quantification |